@the_real_mchenz @jtrebach While improved pharmacokinetics are appreciated, it's not entirely clear that new formulations result in better clinical outcomes and warrant a *century* of patent protection. For example, compare NPH insulin (1947 patent) to gl
RT @CochraneUK: (Ultra‐)long‐acting #insulin analogues compared with NPH insulin (human isophane insulin) for adults with #type2diabetes me…
(Ultra‐)long‐acting #insulin analogues compared with NPH insulin (human isophane insulin) for adults with #type2diabetes mellitus https://t.co/z9iiB6h2VN Updated @CochraneAbdoEnd review includes 24 RCTs. "The different insulins reduced HbA1c by about the s